Oncology Journal Articles

• Prospective Genomic Profiling in Metastatic Breast Cancer Genomic profiling in metastatic breast cancer could have important prognostic and therapeutic implications.
  Breast Cancer Research, October 28, 2020
• Sustained Weight Loss and Breast Cancer Risk in Older Women Sustaining even a modest amount of weight loss later in life may be associated with a lower risk for developing breast cancer, a new study reports.
  Journal of the National Cancer Institute, October 28, 2020
• Radiomics to Predict Treatment Sensitivity in Metastatic CRC Could the radiomics response signature accurately predict anti-EGFR treatment sensitivity in colorectal cancer patients with liver metastases?
  Journal of the National Cancer Institute, October 14, 2020
• Sexual and Gender Minority Cultural Training for Oncologists Are oncology clinicians adequately trained to address the unique health needs of sexual and gender minority individuals?
  Journal of Clinical Oncology, October 09, 2020
• Why Aren't We Choosing Wisely? The Choosing Wisely guidelines are intended to reduce unnecessary tests and procedures, but implementing these recommendations into practice may be challenging. This editorial explores the issue.
  Journal of Oncology Practice, October 09, 2020
• Prognostic Biomarkers in NSCLC Treated With Immunotherapy What can these potential biomarkers tell us about the prognosis of immunotherapy-treated non-small cell lung cancer?
  Translational Lung Cancer Research, October 05, 2020
• Insulin Resistance and Racial Disparities in BC Prognosis Is insulin resistance a contributing factor to the racial disparities in breast cancer prognosis? A new study examines the possibility.
  Breast Cancer Research, September 28, 2020
• Impact of Overweight and Obesity on Thyroid Cancer Incidence The incidence of papillary thyroid cancer is on the rise in recent years, as is the prevalence of obesity. Is there a connection?
  Journal of the National Cancer Institute, September 23, 2020
• Genomic Profiling Detects Smoldering Multiple Myeloma Risk Could genomic profiling accurately predict which patients with smoldering multiple myeloma are at risk for progression? Find out what there is to know.
  Journal of Clinical Oncology, September 15, 2020
• Safety of Flu Vaccine in Cancer Patients on Pembrolizumab A new study finds that it is safe for pembrolizumab-treated cancer patients to receive an influenza vaccination, with no increase in reported adverse events.
  Journal of Oncology Practice, September 15, 2020
• Prostate Cancer Outcomes After Solid-Organ Transplantation Might a history of solid organ transplantation influence prostate cancer outcomes? How should cancer be managed in these patients?
  Journal of the National Cancer Institute, September 09, 2020
• Role of Chest Radiographs in Early Lung Cancer Detection Low-dose CT is traditionally used in the screening of patients at risk for lung cancer, but it has its limitations. Might chest radiography provide a viable alternative?
  Translational Lung Cancer Research, September 04, 2020
• COVID-19 in Breast Cancer Patients What have we learned about the outcomes of patients diagnosed with COVID-19 during breast cancer treatment?
  Breast Cancer Research, August 27, 2020
• Unraveling TNBC Tumor Microenvironment Heterogeneity A better understanding of the tumor microenvironment heterogeneity in triple-negative breast cancer could have important implications for treatment targets.
  Journal of the National Cancer Institute, August 25, 2020
• RVD Induction Therapy in Newly Diagnosed Multiple Myeloma What benefits might be achieved with a combination lenalidomide, bortezomib, and dexamethasone induction regimen in patients with multiple myeloma?
  Journal of Clinical Oncology, August 17, 2020
• Treating Sexual and Gender Minority Patients With Cancer Sexual and gender minority individuals may face significant health disparities when accessing cancer care. What can oncologists do to improve their experience?
  Journal of Oncology Practice, August 13, 2020
• ER-Borderline Breast Cancers in Black and White Women What have we learned about the characteristics and outcomes of ER-borderline tumors? Do they differ between black and white women?
  Journal of the National Cancer Institute, August 11, 2020
• PD-1/L1 Inhibitors for NSCLC in Front-Line Treatment Are PD-1/L1 inhibitors a safe and effective option for the front line treatment of patients with advanced non-small cell lung cancer?
  Translational Lung Cancer Research, August 07, 2020
• Cladribine With Concurrent or Delayed Rituximab in HCL Could the addition of rituximab to cladribine treatment help clear minimal residual disease in patients with hairy cell leukemia?
  Journal of Clinical Oncology, August 03, 2020
• Philadelphia Chromosome-Negative B-Cell ALL in Young Adults The outcomes and prognosis of adolescents and young adults with Philadelphia chromosome-negative ALL differs from that of younger children. How are these older patients best managed?
  Journal of Oncology Practice, July 30, 2020